This blog relates to the business and environment of chemistry R&D as it impacts on new drug development within the Pharmaceutical or Biotech industry from the perspective of a supplier company. I will post items that interest me and may interest the chemical development community. I will pass on my thoughts, for what they are worth, give opinions and offer relevant topics for discussion.
Wednesday, 10 August 2011
Onyx Scientific under new ownership
Onyx Scientific reports that it has been acquired by Ipca Laboratories UK Ltd (see here), the UK arm of Indian pharmaceutical company Ipca Laboratories. At a presentation to our staff on Tuesday I stated that there wouldn't be any job changes at Onyx but was contradicted by Pranay Godha, Executive Director of Ipca. He stated that he expected an increase in the numbers at Sunderland as the company grew, as we aim to double the size of the company. There will be considerable synergies as the Onyx-Covance group can now offer all scales of chemistry from medicinal chemistry to commercial manufacture.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment